What's in Sol-Gel Technologies, Ltd.'s pipeline?

Sol-Gel Technologies, Ltd. has 12 drugs in our index: 1 marketed, 0 filed, 4 in Phase 3, 5 in Phase 2, 2 in Phase 1.

Which companies overlap with Sol-Gel Technologies, Ltd.'s portfolio?

Top competitors by shared drug class: Galderma R&D, Army Medical University, China, Dr. Emmy Graber, Center for Sight Las Vegas, Centro Dermatológico Dr. Ladislao de la Pascua.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/sol-gel-technologies-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-10 · How we verify

Sol-Gel Technologies, Ltd. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Sol-Gel Technologies, Ltd. pipeline: 1 marketed, 0 filed, 4 Phase 3, 5 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 4 Phase 3 5 Phase 2 2 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Efudex®	Efudex®	marketed
S6G5T-8	S6G5T-8	phase 3			Ophthalmology
S6G5T-3	S6G5T-3	phase 3	topical retinoid	sebaceous glands	Dermatology
S5G4T-2	S5G4T-2	phase 3	Retinoid	Retinoic acid receptors	Dermatology
Patidegib Topical Gel	Patidegib Topical Gel	phase 3	Smoothened (SMO) inhibitor	Smoothened (SMO)	Oncology

Therapeutic area mix

Dermatology · 2
Oncology · 1
Ophthalmology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Galderma R&D · 2 shared drug classes
Army Medical University, China · 1 shared drug class
Dr. Emmy Graber · 1 shared drug class
Center for Sight Las Vegas · 1 shared drug class
Centro Dermatológico Dr. Ladislao de la Pascua · 1 shared drug class
Cipher Pharmaceuticals Inc. · 1 shared drug class
Bausch Health Americas, Inc. · 1 shared drug class
Actavis Inc. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Sol-Gel Technologies, Ltd.:

Cite this brief

Drug Landscape (2026). Sol-Gel Technologies, Ltd. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/sol-gel-technologies-ltd. Accessed 2026-06-10.